Skip to main content
. Author manuscript; available in PMC: 2015 Jan 7.
Published in final edited form as: AIDS. 2013 May 15;27(8):1199–1208. doi: 10.1097/QAD.0b013e32835ecb8b

Fig. 1.

Fig. 1

Schematic representation of the potential causes of chronic immune activation in HIV-infected patients, its impact on clinical end-points, and strategies of interventions tested in recently completed and ongoing clinical trials.